| 1 | 516-38-1 | α-Cortol | α-Cortol | C21H36O5
| | |
| 2 | 35700-23-3 | Carboprost | Carboprost | C21H36O5
| | |
| 3 | 154639-24-4 | 4-hexadecanoyl-3-hydroxy-2-(hydroxymethyl)-2H-furan-5-one | (Rac)-RK-682 | C21H36O5
| 微生物代谢物 | |
| 4 | 76498-29-8 | 卡前列素氨丁三醇EP杂质A | trans-Carboprost | C21H36O5
| 对照品;杂质对照品 | |
| 5 | 1403-17-4 | 杀念菌素 | CANDICIDIN (200 MG) | C21H36O5
| | |
| 6 | 73036-29-0 | protoconstipatic acid | protoconstipatic acid | C21H36O5
| | |
| 7 | 41692-11-9 | 前列腺素杂质 2 | Prostaglandin E1 Impurity 2 | C21H36O5
| | |
| 8 | 3434-33-1 | PROSTAGLANDIN E1 METHYL ESTER | PROSTAGLANDIN E1 METHYL ESTER | C21H36O5
| | |
| 9 | 35700-26-6 | 15(S)- 15甲基前列腺素E1 | 15(S)-15-METHYL PROSTAGLANDIN E1 | C21H36O5
| | |
| 10 | 33854-16-9 | 地诺前列素甲酯 | PROSTAGLANDINS F2ALPHA METHYL ESTER | C21H36O5
| 杂质对照品;对照品-杂质对照品 | |
| 11 | 79743-27-4 | prostaglandin F2alpha 9-methyl ether | prostaglandin F2alpha 9-methyl ether | C21H36O5
| | |
| 12 | 35864-81-4 | 15(R)-15-METHYL PROSTAGLANDIN F2ALPHA | 15(R)-15-METHYL PROSTAGLANDIN F2ALPHA | C21H36O5
| | |
| 13 | 516-39-2 | Allopregnane-3B,11B,17ALPHA,20B-21-pentol | Allopregnane-3B,11B,17ALPHA,20B-21-pentol | C21H36O5
| | |
| 14 | 65659-61-2 | 15(S)-15-methyl delta(4)-prostaglandin F1alpha | 15(S)-15-methyl delta(4)-prostaglandin F1alpha | C21H36O5
| | |
| 15 | 3513-00-6 | (17S,20R)-5α-Pregnane-3β,12β,14β,17,20-pentol | (17S,20R)-5α-Pregnane-3β,12β,14β,17,20-pentol | C21H36O5
| | |
| 16 | | 5-BETA-PREGNAN-3-BETA, 11-BETA, 17,20-BETA, 21-PENTOL | 5-BETA-PREGNAN-3-BETA, 11-BETA, 17,20-BETA, 21-PENTOL | C21H36O5
| | |
| 17 | | 5-ALPHA-PREGNAN-3-BETA, 11-BETA, 17,20-BETA, 21-PENTOL | 5-ALPHA-PREGNAN-3-BETA, 11-BETA, 17,20-BETA, 21-PENTOL | C21H36O5
| | |
| 18 | 71960-75-3 | 3-[2-hydroxy-3-(4-nonylphenoxy)propoxy]propane-1,2-diol | 3-[2-hydroxy-3-(4-nonylphenoxy)propoxy]propane-1,2-diol | C21H36O5
| | |
| 19 | | PREGNAN-3-BETA, 5-ALPHA, 6-BETA, 16-BETA, 20-ALPHA-PENTOL | PREGNAN-3-BETA, 5-ALPHA, 6-BETA, 16-BETA, 20-ALPHA-PENTOL | C21H36O5
| | |
| 20 | 112137-89-0 | 米索前列醇自由酸 | (+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1 | C21H36O5
| | |
| 21 | 150627-37-5 | (R)-4-Hydroxy-5-(hydroxymethyl)-3-(1-oxohexadecyl)-2(5H)-furanone | (R)-4-Hydroxy-5-(hydroxymethyl)-3-(1-oxohexadecyl)-2(5H)-furanone | C21H36O5
| | |
| 22 | 41691-84-3 | Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9α,11α,13E)- | Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9α,11α,13E)- | C21H36O5
| | |
| 23 | 73036-28-9 | 3-Furancarboxylic acid, 2,5-dihydro-2-(14-hydroxypentadecyl)-4-methyl-5-oxo- (9CI) | 3-Furancarboxylic acid, 2,5-dihydro-2-(14-hydroxypentadecyl)-4-methyl-5-oxo- (9CI) | C21H36O5
| | |
| 24 | | 3-Methyl-6-nonyl-6-(tetrahydro-2H-pyran-2-yloxymethyl)tetrahydro-2H-pyran-2,4-dione | 3-Methyl-6-nonyl-6-(tetrahydro-2H-pyran-2-yloxymethyl)tetrahydro-2H-pyran-2,4-dione | C21H36O5
| | |
| 25 | 101899-68-7 | 3-Furancarboxylic acid, tetrahydro-4-methyl-5-oxo-2-(14-oxopentadecyl)-, (2S,3S,4S)- | 3-Furancarboxylic acid, tetrahydro-4-methyl-5-oxo-2-(14-oxopentadecyl)-, (2S,3S,4S)- | C21H36O5
| | |
| 26 | 22748-58-9 | 3,4-dihydroxy-4-(1-hydroxy-4-methylpentyl)-5-(3-methylbutyl)-2-(3-methyl-1-oxobutyl)cyclopent-2-en-1-one | 3,4-dihydroxy-4-(1-hydroxy-4-methylpentyl)-5-(3-methylbutyl)-2-(3-methyl-1-oxobutyl)cyclopent-2-en-1-one | C21H36O5
| | |
| 27 | 85269-23-4 | (2S,4aα,8aβ)-3,4,4a,5,6,7,8,8a-Octahydro-2,7β-dihydroxy-4α-(3-hydroxy-1-oxopropyl)-2,4β,5α,7α-tetramethyl-3α-[(R)-1-methylpropyl]-1(2H)-naphthalenone | (2S,4aα,8aβ)-3,4,4a,5,6,7,8,8a-Octahydro-2,7β-dihydroxy-4α-(3-hydroxy-1-oxopropyl)-2,4β,5α,7α-tetramethyl-3α-[(R)-1-methylpropyl]-1(2H)-naphthalenone | C21H36O5
| | |